PHARMA

Quarterly rpt on consolidated results for the financial period ended 30/9/2012

Amended Announcements
Please refer to the earlier announcement reference number: PB-121105-52853

PHARMANIAGA BERHAD

Financial Year End

31/12/2012
Quarter3
Quarterly report for the financial period ended30/09/2012
The figureshave not been audited

Attachments

KLSE1209.pdf
246 KB

  • Default Currency
  • Other Currency

Currency: Malaysian Ringgit (MYR)

SUMMARY OF KEY FINANCIAL INFORMATION
30/09/2012

 
INDIVIDUAL PERIOD
CUMULATIVE PERIOD
CURRENT YEAR QUARTER
PRECEDING YEAR
CORRESPONDING
QUARTER
CURRENT YEAR TO DATE
PRECEDING YEAR
CORRESPONDING
PERIOD
30/09/2012
30/09/2011
30/09/2012
30/09/2011
$$'000
$$'000
$$'000
$$'000
1Revenue
426,460
371,432
1,329,942
1,153,195
2Profit/(loss) before tax
28,493
15,646
99,066
56,818
3Profit/(loss) for the period
25,536
10,959
70,674
40,603
4Profit/(loss) attributable to ordinary equity holders of the parent
25,247
10,811
69,645
40,215
5Basic earnings/(loss) per share (Subunit)
21.46
9.19
59.18
34.17
6Proposed/Declared dividend per share (Subunit)
10.00
0.00
25.00
0.00


AS AT END OF CURRENT QUARTER
AS AT PRECEDING FINANCIAL YEAR END
7
Net assets per share attributable to ordinary equity holders of the parent ($$)
4.2200
3.9800

Remarks :
The Basic Earnings per Share ("EPS") for the preceding year corresponding quarter and period and Net Assets per Share for the preceding financial year end have been restated to reflect the retrospective adjustments arising from the bonus issue which was completed on 20 February 2012.
Definition of Subunit:

In a currency system, there is usually a main unit (base) and subunit that is a fraction amount of the main unit.
Example for the subunit as follows:

CountryBase UnitSubunit
MalaysiaRinggitSen
United StatesDollarCent
United KingdomPoundPence

Announcement Info

Company NamePHARMANIAGA BERHAD  
Stock Name PHARMA    
Date Announced6 Nov 2012  
CategoryFinancial Results
Reference NoPB-121106-4A988

View original report